Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses
Research and development	$ 27,247	$ 11,179	$ 59,229	$ 29,025
General and administrative	5,018	4,860	15,191	13,627
Total operating expenses	32,265	16,039	74,420	42,652
Loss from operations	(32,265)	(16,039)	(74,420)	(42,652)
Other income (expense)
Interest income	3,504	3,124	11,325	6,840
Interest expense	(1,027)	0	(3,031)	0
Change in fair value of embedded derivatives	(10)	0	1,040	0
Other income (expense), net	33	(42)	(89)	(62)
Total other income	2,500	3,082	9,245	6,778
Net loss	(29,765)	(12,957)	(65,175)	(35,874)
Other comprehensive gain (loss)
Unrealized gain on marketable securities	682	137	206	242
Comprehensive loss	$ (29,083)	$ (12,820)	$ (64,969)	$ (35,632)
Net loss per common share, basic (in dollars per share)	$ (0.50)	$ (0.24)	$ (1.09)	$ (0.79)
Net loss per common share, diluted (in dollars per share)	$ (0.50)	$ (0.24)	$ (1.09)	$ (0.79)
Weighted-average shares outstanding, basic (in shares)	60,079,778	54,229,630	59,990,844	45,474,953
Weighted-average shares outstanding diluted (in shares)	60,079,778	54,229,630	59,990,844	45,474,953